EUROPACORP (ALECP.PA) Fundamental Analysis & Valuation

EPA:ALECP • FR0010490920

Current stock price

0.378 EUR
-0.01 (-3.08%)
Last:

This ALECP.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ALECP.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALECP has reported negative net income.
  • In the past year ALECP had a positive cash flow from operations.
  • Of the past 5 years ALECP 4 years were profitable.
  • Each year in the past 5 years ALECP had a positive operating cash flow.
ALECP.PA Yearly Net Income VS EBIT VS OCF VS FCFALECP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

  • ALECP has a Return On Assets of -2.37%. This is in the lower half of the industry: ALECP underperforms 63.64% of its industry peers.
Industry RankSector Rank
ROA -2.37%
ROE N/A
ROIC N/A
ROA(3y)-1.27%
ROA(5y)19.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALECP.PA Yearly ROA, ROE, ROICALECP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5K 10K 15K

1.3 Margins

  • With a Gross Margin value of 22.50%, ALECP is not doing good in the industry: 86.36% of the companies in the same industry are doing better.
  • ALECP's Gross Margin has declined in the last couple of years.
  • ALECP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.32%
GM growth 5Y-14.72%
ALECP.PA Yearly Profit, Operating, Gross MarginsALECP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ALECP.PA Health Analysis

2.1 Basic Checks

  • ALECP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALECP has more shares outstanding
  • Compared to 5 years ago, ALECP has more shares outstanding
  • ALECP has about the same debt/assets ratio as last year.
ALECP.PA Yearly Shares OutstandingALECP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ALECP.PA Yearly Total Debt VS Total AssetsALECP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of -2.36, we must say that ALECP is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -2.36, ALECP is doing worse than 88.64% of the companies in the same industry.
  • The Debt to FCF ratio of ALECP is 28.76, which is on the high side as it means it would take ALECP, 28.76 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of ALECP (28.76) is worse than 61.36% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 28.76
Altman-Z -2.36
ROIC/WACCN/A
WACC5.08%
ALECP.PA Yearly LT Debt VS Equity VS FCFALECP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

2.3 Liquidity

  • ALECP has a Current Ratio of 1.16. This is a normal value and indicates that ALECP is financially healthy and should not expect problems in meeting its short term obligations.
  • ALECP has a Current ratio of 1.16. This is in the better half of the industry: ALECP outperforms 65.91% of its industry peers.
  • ALECP has a Quick Ratio of 1.16. This is a normal value and indicates that ALECP is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ALECP (1.16) is better than 65.91% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
ALECP.PA Yearly Current Assets VS Current LiabilitesALECP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ALECP.PA Growth Analysis

3.1 Past

  • ALECP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.50%, which is quite impressive.
  • The Revenue has been growing slightly by 1.89% in the past year.
  • ALECP shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -14.67% yearly.
EPS 1Y (TTM)48.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.6%
Revenue 1Y (TTM)1.89%
Revenue growth 3Y-3.65%
Revenue growth 5Y-14.67%
Sales Q2Q%21.22%

3.2 Future

  • ALECP is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -38.96% yearly.
  • The Revenue is expected to decrease by -35.46% on average over the next years. This is quite bad
EPS Next Y-49.12%
EPS Next 2Y-38.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-53.15%
Revenue Next 2Y-35.46%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALECP.PA Yearly Revenue VS EstimatesALECP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ALECP.PA Yearly EPS VS EstimatesALECP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

4

4. ALECP.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALECP. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 8.28, the valuation of ALECP can be described as reasonable.
  • ALECP's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALECP is cheaper than 93.18% of the companies in the same industry.
  • ALECP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.24.
Industry RankSector Rank
PE N/A
Fwd PE 8.28
ALECP.PA Price Earnings VS Forward Price EarningsALECP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALECP indicates a somewhat cheap valuation: ALECP is cheaper than 70.45% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, ALECP is valued a bit cheaper than the industry average as 65.91% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 23.5
EV/EBITDA 6.07
ALECP.PA Per share dataALECP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2

4.3 Compensation for Growth

  • ALECP's earnings are expected to decrease with -38.96% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-38.96%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALECP.PA Dividend Analysis

5.1 Amount

  • ALECP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALECP.PA Fundamentals: All Metrics, Ratios and Statistics

EUROPACORP

EPA:ALECP (4/24/2026, 7:00:00 PM)

0.378

-0.01 (-3.08%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)12-11
Earnings (Next)05-26
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners13.1%
Ins Owner ChangeN/A
Market Cap47.41M
Revenue(TTM)33.99M
Net Income(TTM)-1.94M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.28
P/S 1.39
P/FCF 23.5
P/OCF 3.04
P/B N/A
P/tB N/A
EV/EBITDA 6.07
EPS(TTM)-0.02
EYN/A
EPS(NY)0.05
Fwd EY12.07%
FCF(TTM)0.02
FCFY4.25%
OCF(TTM)0.12
OCFY32.89%
SpS0.27
BVpS-0.03
TBVpS-0.29
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -2.37%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.5%
FCFM 5.93%
ROA(3y)-1.27%
ROA(5y)19.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.32%
GM growth 5Y-14.72%
F-Score5
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 28.76
Debt/EBITDA 2.53
Cap/Depr 74.8%
Cap/Sales 39.95%
Interest Coverage N/A
Cash Conversion 88.56%
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z -2.36
F-Score5
WACC5.08%
ROIC/WACCN/A
Cap/Depr(3y)110.61%
Cap/Depr(5y)70.32%
Cap/Sales(3y)61.29%
Cap/Sales(5y)38.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.6%
EPS Next Y-49.12%
EPS Next 2Y-38.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.89%
Revenue growth 3Y-3.65%
Revenue growth 5Y-14.67%
Sales Q2Q%21.22%
Revenue Next Year-53.15%
Revenue Next 2Y-35.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-31.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y132.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.59%
OCF growth 3Y0.62%
OCF growth 5Y-7.81%

EUROPACORP / ALECP.PA Fundamental Analysis FAQ

What is the fundamental rating for ALECP stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALECP.PA.


What is the valuation status for ALECP stock?

ChartMill assigns a valuation rating of 4 / 10 to EUROPACORP (ALECP.PA). This can be considered as Fairly Valued.


What is the profitability of ALECP stock?

EUROPACORP (ALECP.PA) has a profitability rating of 2 / 10.


What is the financial health of EUROPACORP (ALECP.PA) stock?

The financial health rating of EUROPACORP (ALECP.PA) is 2 / 10.